Johnson & Johnson has added another piece to the data behind its effort to move Tecvayli into earlier-line therapy for ...

Novartis has published an open letter to governments around the world, and particularly the EU, Canada, and Japan, urging ...

Top of the list is that AIs must be human-centric by design and align with ethical values. They must be developed using a ...

With attention in biotech focused on the JPM Healthcare conference in the US, the Novo Nordisk Foundation (NNF) has flown the ...

Amber Implants, a Netherlands medtech developing next-generation implants for spinal injuries, named Vincent Gardès as CEO.

On-site on the sidelines of JP Morgan Healthcare conference in San Francisco this year, pharmaphorum editor-in-chief Jonah ...

UK contract development and manufacturing organisation (CDMO) Oxford BioMedica confirmed this morning that it has received an ...

Novo Nordisk's new chief executive, Mike Doustdar, has told the JPM Healthcare conference that the key to competing in the ...

For the US, it means that the UK will spend more on medicines and offer more support to industry. Over the next ten years, ...

The BioIndustry Association (BIA) has also announced its new CEO to replace Steve Bates, who stepped down last September to ...

Meanwhile, the FDA has asked manufacturers of flu vaccines to update their labels to include warnings about the risk of ...

Hippocratic AI has expanded its focus with the acquisition of Grove AI, a specialist in AI used in pharma R&D, to complement ...